10.46243/jst.2020.v5.i3.pp19-24 registered
Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review
Resolves to https://www.jst.org.in/index.php/pub/article/view/333
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i3.pp19-24
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 0731ce686ad56bda…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML (not for this record) · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review (PrincipalTitle · en)
Published 2020-04-29
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 5 · issue 3 · pages 19–24
Agents
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2020.v5.i3.pp19-24
Abstract · en
Recently, aptamers get the attention of many scientist, because they have all advantages of antibodies which found in human body. They also have unique merits like thermal stability, low cost, and many more. Aptamers are the short sequence nucleic acid with a high affinity and specificity. It is globally adopted as a one of the advance and promising drug delivery technique. These aptamers are produced by in vitro selection method using SELEX technique. This review contains the discussion on the aspect of design, unique properties, applications of aptamers to aid in cancer diagnosis, prevention and treatment under fine condition. Finally, several medical and analytical applications are presented.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2020.v5.i3.pp19-24 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | publisher: Longman Publishers published: 2020-04-29 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 5 · no. 3 · pp. 19–24 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2020-04-29 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
Recommended for a journal article and not in this record: its author(s), editor(s) or corporate author.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 23 references; 23 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Zhang,Y.,et.al. Tumor-Targeted Drug Delivery with Aptamers. Curr. Med. Chem.2011. 18(27): 4185-94 | 10.2174/092986711797189547 | not held here |
| 2 | ref2 Sun,H.et al. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy. Molecular Therapy Nucleic Acids. 2014.3, e182. Doi: 10.1038/mtna.2014.32 | 10.1038/mtna.2014.32 | not held here |
| 3 | ref3 Jayasena, S.D. Apatmers: An emerging class of molecules that rival antibodies in diagnostics. Clinical Chemistry.1999.45(9): 1628-50 | 10.1093/clinchem/45.9.1628 | not held here |
| 4 | ref4 Vinkenborg, J.L.,et al. Aptamers for allosteric regulations. Nature Chemical Biology. August 2011.7;519-27 | 10.1038/nchembio.609 | not held here |
| 5 | ref5 Xu, Li, et al. Cellular Internalization and Cytotoxicity of Aptamers Selected from Lung Cancer cell. American Journal of Biomedical Sciences. 24 December 2012 | 10.5099/aj130100047 | not held here |
| 6 | ref6 Kabori, S.et al. Kinetic analysis of aptazyme-regulated gene expression in a cell- free translation system: Modeling of liganddependant and-independent expression. RNA.2012.18(8):… | 10.1261/rna.032748.112 | not held here |
| 7 | ref7 A.V. Lakhin, V.Z. Taranful, Aptamers: Problems, Solution and Prospects, Acta Naturae. 2013 Oct-Dec; 5(4): 34–43 | 10.32607/20758251-2013-5-4-34-43 | not held here |
| 8 | ref8 Colas P, Cohen B, “Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependant kinase 2” Nature 380(6574):548-50 | 10.1038/380548a0 | not held here |
| 9 | ref9 Mohamad H. Ali, Marwa E. Elsherbiny, Review update on aptamer research. Int. J. Mol. Sci. 2019, 20,2511 | 10.3390/ijms20102511 | not held here |
| 10 | ref10 Yang Zhang,BoShiun Lai, Review on Recent Advances in Aptamer Discovery and Application, Molecules 2019,24 | 10.3390/molecules24050941 | not held here |
| 11 | ref11 ZhenjjanZhuo, Yuanyanyu, Recent Advances in SELEX Technology and Aptamer Application in Biomedicine, Int. J. Mol.Sci, 2017, 18 (10):2142 | 10.3390/ijms18102142 | not held here |
| 12 | ref12 Tatjana Schutze, Barbara Wilhelm, Probing the SELEX Process with Next–Generation Sequencing,Journal pone,2011 | 10.1371/journal.pone.0029604 | not held here |
| 13 | ref13 Baby Santosh, Promad, K, Yadava, Review article on Nucleic Acid Aptamers: Research Tool in Disease Diagnostic and Therapeutics, BioMed Research International Volume 2014 | 10.1155/2014/540451 | not held here |
| 14 | ref14 D. J. Stickle,J.B. King, Blockage of uretheral catheters by bacterial biofilms, Journal of Infection,1993, Vol.27,no.2, P.NO. 133- | 10.1016/0163-4453(93)94620-q | not held here |
| 15 | ref15 W. C. Winkler, R. R. Breaker, “ Regulation of bacterial gene expression by riboswitches, Annual Review of Microbiology, 2005, vol.29, P.No- 487-517 | 10.1146/annurev.micro.59.030804.121336 | not held here |
| 16 | ref16 Kyung Mi-Song,Seonghwan Lee, “Aptamer and Their Biological Application,’’ Sensors 2012, 12, 612-631 | 10.3390/s120100612 | not held here |
| 17 | ref17 B. J. Tucker and R.R. Breaker, Riboswitches as versatile gene control element, Current Opinion in Structural Biology,2005, vol. 15, no.3, P.No. 342-348.expected places, Wiley Inter | 10.1016/j.sbi.2005.05.003 | not held here |
| 18 | ref18 K. Matyalla-Kulinska, J.L. Boots, Finding aptamers and small ribozymes in unexpected place, Wiley Interdisciplinary Review : RNA, 2012, vol.3, no.1, P.No.73-91 | 10.1002/wrna.105 | not held here |
| 19 | ref19 Y.Wan, Y.Kim, N.et al., “Surface-immobilized aptamers for cancer cell isolation and microscopic cytology’’ Cancer Research, 2010,vol.70,no.22, P.No-9371-9380 | 10.1158/0008-5472.can-10-0568 | not held here |
| 20 | ref20 P.Zhang, N. Zhao, “ Using an RNA Aptamer probe for flow cytometry detection of CD30 expressing lymphoma cells’’ Laboratory Investigation,2009,vol.89,no.12, P.No-1423-1432 | 10.1038/labinvest.2009.113 | not held here |
| 21 | ref21 D.H.J. Bunka, P.G. Stockley, “Aptamers come of age-at last’’ Nature Reviews Microbiology, 2006,vol.4, no.8, P.No-588-596 | 10.1038/nrmicro1458 | not held here |
| 22 | ref22 T.G. McCauley, N. Hamaguchi, “Aptamer based biosensor arrays for detection and quantification of biological macromolecules’’, Analytical Biochemistry, 2003,vol.319, no.2,P.No- 244… | 10.1016/s0003-2697(03)00297-5 | not held here |
| 23 | ref23 S. Sivanesan, M.D. Howell,” Antisense oligonucleotide mediate therapy of spinal muscular atropy,’’ Translational Neuroscience,2013,vol.4, no.1, P.No-1-7 | 10.2478/s13380-013-0109-2 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 117 fields set · sha256 32a681c3bc8e… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.



